This article provides a thorough overview of the pathophysiology and current treatment options for myasthenia gravis, an autoimmune and antibody-mediated neuromuscular disease.

A retrospective analysis of patients with acetylcholine receptor antibody (AChR-Ab)-positive generalized myasthenia gravis (MG) who underwent thymectomy found that a majority of them had good long ...

The thymus plays an important pathogenetic role in AChR antibody-associated MG. Most patients, and especially those with early-onset MG, have an enlarged and hyperplastic thymus.

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Sunshine Cruz recently revealed that she’s battling an autoimmune disease called myasthenia gravis. In an Instagram post, the actress said that the past months have been a "real rollercoaster ...

The patients serum contained antibodies against striated muscle 11 (titer of 1:480), which occur in nearly all patients with myasthenia gravis and thymoma, but also occur in 25 per cent of cases ...

Thymoma screening is recommended at the onset of myasthenia gravis (MG) or when patients with MG present with clinical deterioration or a progressive increase of anti-acetylcholine receptor antibody.

The final, formatted version of the article will be published soon. Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomicsXiaoting Lin ...

Background Myasthenia gravis (MG) represents a heterogeneous group of autoantibody-mediated diseases targeting the neuromuscular junction. Extraocular muscles (EOMs) are highly susceptible to ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile.